Acute Myeloid Leukemia Clinical Trial
A Patient-centered Communication Tool (UR-GOAL) for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists
Summary
This is a pilot study to evaluate the usability and feasibility of a patient-centered communication tool (University of Rochester-Geriatric Oncology Assessment for acute myeloid Leukemia or UR-GOAL) among 15 older patients with AML, their caregivers, and oncologists.
Full Description
Older adults with AML and their caregivers may benefit from help and support in understanding their treatment options. This pilot study seeks to evaluate the usability and feasibility of the UR-GOAL communication tool. The UR-GOAL tool will incorporate conjoint analysis to elicit patient preferences as well as assessments of fitness and prognostic awareness.
Eligibility Criteria
Inclusion Criteria for Patients:
Age ≥60 years (conventional definition of older age in AML)
Newly diagnosed AML
Considering treatment
Able to provide informed consent
English-speaking
Inclusion Criteria for Caregivers:
Selected by the patient when asked if there is a "family member, partner, friend or caregiver [age 21 or older] with whom you discuss or who can be helpful in health-related matters;" patients who cannot identify such a person ("caregiver") can be eligible for the study. A caregiver need not be someone who lives with the patient or provides direct hands-on care. A caregiver can be any person who provides support (in any way) to the patient.
Able to provide informed consent
English-speaking
Inclusion Criteria for Oncologists:
A practicing oncologist
At least one of their patients are recruited to the study
English-speaking
Exclusion Criteria: None
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Rochester New York, 14623, United States
How clear is this clinincal trial information?